Nalaganje...
Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease
AIM: To evaluate the inflammasome activation and the effect of peroxisome proliferator-activated receptors (PPAR)-δ agonist treatment in nonalcoholic fatty liver disease (NAFLD) models. METHODS: Male C57BL/6J mice were classified according to control or high fat diet (HFD) with or without PPAR-δ ago...
Shranjeno v:
izdano v: | World J Gastroenterol |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Baishideng Publishing Group Inc
2015
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4671034/ https://ncbi.nlm.nih.gov/pubmed/26668503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i45.12787 |
Oznake: |
Označite
Brez oznak, prvi označite!
|